Proniosomal gel-mediated transdermal delivery of bromocriptine: in vitro and ex vivo evaluation

References

• Tomoda K, Makino K. Chapter 7 – Nanoparticles for transdermal drug delivery system (TDDS). In: Makino HO, editor. Colloid and interface science in pharmaceutical research and development. Amsterdam: Elsevier; 2014. p. 131–147.
   Google Scholar
• Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008;26:1261–1268.
   PubMed Web of Science ®Google Scholar
• Ita K. Transdermal delivery of drugs with microneedles: Strategies and outcomes. J Drug Deliv Sci Technol. 2015;29:16–23.
   Web of Science ®Google Scholar
• Wiedersberg S, Guy RH. Transdermal drug delivery: 30+ years of war and still fighting! J Control Release. 2014;190:150–156.
   PubMed Web of Science ®Google Scholar
• Moghassemi S, Hadjizadeh A. Nano-niosomes as nanoscale drug delivery systems: an illustrated review. J Control Release. 2014;185:22–36.
   PubMed Web of Science ®Google Scholar
• Lauterbach A, Muller-Goymann CC. Applications and limitations of lipid nanoparticles in dermal and transdermal drug delivery via the follicular route. Eur J Pharm Biopharm. 2015;97:152–163.
   PubMed Web of Science ®Google Scholar
• Abdelkader H, Alani AW, Alany RG. Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations. Drug Deliv. 2014;21:87–100.
   PubMed Web of Science ®Google Scholar
• Yasam VR, Jakki SL, Natarajan J, et al. A review on novel vesicular drug delivery: proniosomes. Drug Deliv. 2014;21:243–249.
   PubMed Web of Science ®Google Scholar
• Rahimpour Y, Kouhsoltani M, Hamishehkar H. Proniosomes in transdermal drug delivery. Curr Pharm Des. 2015;21:2883–2891.
   PubMed Web of Science ®Google Scholar
• Mokale VJ, Patil HI, Patil AP, et al. Formulation and optimisation of famotidine proniosomes: an in vitro and ex vivo study. J Exp Nanosci. 2016;11:97–110.
   Web of Science ®Google Scholar
• Ammar HO, Ghorab M, El-Nahhas SA, et al. Proniosomes as a carrier system for transdermal delivery of tenoxicam. Int J Pharm. 2011;405:142–152.
   PubMed Web of Science ®Google Scholar
• Wen MM, Farid RM, Kassem AA. Nano-proniosomes enhancing the transdermal delivery of mefenamic acid. J Liposome Res. 2014;24:280–289.
   PubMed Web of Science ®Google Scholar
• Abidin L, Mujeeb M, Imam SS, et al. Enhanced transdermal delivery of luteolin via non-ionic surfactant-based vesicle: quality evaluation and anti-arthritic assessment. Drug Deliv. 2015:1–6.
   Google Scholar
• Sandeep G, Reddy V, Devireddy SR. Formulation and evaluation of fluconazole pro-niosomal gel for topical administration. J Appl Pharm Sci. 2014;4:098–104.
   Google Scholar
• Li Q, Li Z, Zeng W, et al. Proniosome-derived niosomes for tacrolimus topical ocular delivery: in vitro cornea permeation, ocular irritation, and in vivo anti-allograft rejection. Eur J Pharm Sci. 2014;62:115–123.
   PubMed Web of Science ®Google Scholar
• Desplantie O, Tremblay-Gravel M, Avram R, et al. The Medical treatment of new-onset peripartum cardiomyopathy: a systematic review of prospective studies. Can J Cardiol. 2015;31:1421–1426.
   PubMed Web of Science ®Google Scholar
• Thongrangsalit S, Phaechamud T, Lipipun V, et al. Bromocriptine tablet of self-microemulsifying system adsorbed onto porous carrier to stimulate lipoproteins secretion for brain cellular uptake. Colloids Surf B Biointerfaces. 2015;131:162–169.
   PubMed Web of Science ®Google Scholar
• Md S, Haque S, Fazil M, et al. Optimised nanoformulation of bromocriptine for direct nose-to-brain delivery: biodistribution, pharmacokinetic and dopamine estimation by ultra-HPLC/mass spectrometry method. Expert Opin Drug Deliv. 2014;11:827–842.
   PubMed Web of Science ®Google Scholar
• Esposito E, Mariani P, Ravani L, et al. Nanoparticulate lipid dispersions for bromocriptine delivery: characterization and in vivo study. Eur J Pharm Biopharm. 2012;80:306–314.
   PubMed Web of Science ®Google Scholar
• Degim IT, Acarturk F, Erdogan D, et al. Transdermal administration of bromocriptine. Biol Pharm Bull. 2003;26:501–505.
   PubMed Web of Science ®Google Scholar
• Abd El-Alim SH, Kassem AA, Basha M. Proniosomes as a novel drug carrier system for buccal delivery of benzocaine. J Drug Deliv Sci Technol. 2014;24:452–458.
   Web of Science ®Google Scholar
• Alsarra IA, Bosela AA, Ahmed SM, et al. Proniosomes as a drug carrier for transdermal delivery of ketorolac. Eur J Pharm Biopharm. 2005;59:485–490.
   PubMed Web of Science ®Google Scholar
• Fang JY, Yu SY, Wu PC, et al. In vitro skin permeation of estradiol from various proniosome formulations. Int J Pharm. 2001;215:91–99.
   PubMed Web of Science ®Google Scholar
• Higuchi T. Mechanism of sustained-action medication. Theoretical Analysis of Rate of Release of Solid Drugs Dispersed in Solid Matrices. J Pharm Sci. 1963;52:1145–1149.
   PubMed Web of Science ®Google Scholar
• Hwang B-Y, Jung B-H, Chung S-J, et al. In vitro skin permeation of nicotine from proliposomes. J Control Release. 1997;49:177–184.
   Web of Science ®Google Scholar
• Goyal G, Garg T, Malik B, et al. Development and characterization of niosomal gel for topical delivery of benzoyl peroxide. Drug Deliv. 2015:1–16.
   Google Scholar
• Singh VS, Gaur RC. Dispersion of cholesterol in aqueous surfactant solutions: interpretation of viscosity data. J Dispers Sci Technol. 1983;4:347–359.
   Web of Science ®Google Scholar
• Uchegbu IF, Florence AT. Non-ionic surfactant vesicles (niosomes): physical and pharmaceutical chemistry. Adv Colloid Interface Sci. 1995;58:1–55.
   Web of Science ®Google Scholar
• Agarwal R, Katare OP, Vyas SP. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. Int J Pharm. 2001;228:43–52.
   PubMed Web of Science ®Google Scholar
• Mokhtar M, Sammour OA, Hammad MA, et al. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm. 2008;361:104–111.
   PubMed Web of Science ®Google Scholar
• Honeywell-Nguyen PL, Bouwstra JA. Vesicles as a tool for transdermal and dermal delivery. Drug Discov Today Technol. 2005;2:67–74.
   PubMedGoogle Scholar
• Hathout RM, Mansour S, Mortada ND, et al. Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies. AAPS PharmSciTech. 2007;8:E1–E12.
   PubMed Web of Science ®Google Scholar
• Subczynski WK, Wisniewska A. Physical properties of lipid bilayer membranes: relevance to membrane biological functions. Acta Biochim Pol. 2000;47:613–625.
   PubMed Web of Science ®Google Scholar
• Abd-Elbary A, El-laithy HM, Tadros MI. Sucrose stearate-based proniosome-derived niosomes for the nebulisable delivery of cromolyn sodium. Int J Pharm. 2008;357:189–198.
   PubMed Web of Science ®Google Scholar
• Guinedi AS, Mortada ND, Mansour S, et al. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int J Pharm. 2005;306:71–82.
   PubMed Web of Science ®Google Scholar
• El-Laithy HM, Shoukry O, Mahran LG. Novel sugar esters proniosomes for transdermal delivery of vinpocetine: preclinical and clinical studies. Eur J Pharm Biopharm. 2011;77:43–55.
   PubMed Web of Science ®Google Scholar
• Van-Abbe N, Nicholas P, Boon E. Exaggerated exposure in topical irritancy and sensitization testing. J Soc Cosmet Chem. 1975;26:173.
   Web of Science ®Google Scholar